ITCA-1601

N/A

Report date: 2025/01/26 19:34:42

Base Information

Drug NameITCA-1601
Drug Alias Nameamylin receptor agonist (Intarcia Therapeutics Inc)ITCA-1601
ClassificationBiologics
Mechanisms of ActionAmylin receptor agonists
TargetsAmylin Receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntarcia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntarcia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A